AR040188A1 - Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva - Google Patents

Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva

Info

Publication number
AR040188A1
AR040188A1 ARP030102079A ARP030102079A AR040188A1 AR 040188 A1 AR040188 A1 AR 040188A1 AR P030102079 A ARP030102079 A AR P030102079A AR P030102079 A ARP030102079 A AR P030102079A AR 040188 A1 AR040188 A1 AR 040188A1
Authority
AR
Argentina
Prior art keywords
radical
group
optionally substituted
straight
independently
Prior art date
Application number
ARP030102079A
Other languages
English (en)
Spanish (es)
Inventor
Dirk Kosemund
Gerd Mueller
Alexander Hillisch
Karl-Heinrich Fritzemeier
Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR040188A1 publication Critical patent/AR040188A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP030102079A 2002-06-11 2003-06-11 Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva AR040188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10226326A DE10226326A1 (de) 2002-06-11 2002-06-11 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene

Publications (1)

Publication Number Publication Date
AR040188A1 true AR040188A1 (es) 2005-03-16

Family

ID=29723144

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030102079A AR040188A1 (es) 2002-06-11 2003-06-11 Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva

Country Status (28)

Country Link
EP (1) EP1517914B1 (cg-RX-API-DMAC7.html)
JP (1) JP4615998B2 (cg-RX-API-DMAC7.html)
KR (1) KR101006612B1 (cg-RX-API-DMAC7.html)
CN (1) CN1293090C (cg-RX-API-DMAC7.html)
AR (1) AR040188A1 (cg-RX-API-DMAC7.html)
AT (1) ATE303397T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003242683B9 (cg-RX-API-DMAC7.html)
BR (1) BR0312140A (cg-RX-API-DMAC7.html)
CA (1) CA2486495C (cg-RX-API-DMAC7.html)
CR (1) CR10289A (cg-RX-API-DMAC7.html)
CU (1) CU23414B7 (cg-RX-API-DMAC7.html)
DE (2) DE10226326A1 (cg-RX-API-DMAC7.html)
DK (1) DK1517914T3 (cg-RX-API-DMAC7.html)
EA (1) EA008442B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP055530A (cg-RX-API-DMAC7.html)
ES (1) ES2248770T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050009B1 (cg-RX-API-DMAC7.html)
IL (1) IL165321A (cg-RX-API-DMAC7.html)
MX (1) MXPA04012491A (cg-RX-API-DMAC7.html)
NO (1) NO329563B1 (cg-RX-API-DMAC7.html)
PE (1) PE20040613A1 (cg-RX-API-DMAC7.html)
PL (1) PL209910B1 (cg-RX-API-DMAC7.html)
RS (1) RS50878B (cg-RX-API-DMAC7.html)
TW (1) TWI286140B (cg-RX-API-DMAC7.html)
UA (1) UA78062C2 (cg-RX-API-DMAC7.html)
UY (1) UY27844A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003104253A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200500217B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
ES2307064T3 (es) * 2003-11-26 2008-11-16 Bayer Schering Pharma Aktiengesellschaft Prevencion y tratamiento de enfermedades cardiacas hipertensivas por los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,5(10)-trien-3,16alfa-diol.
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
AU2009214307A1 (en) * 2008-02-13 2009-08-20 Bayer Intellectual Property Gmbh Drug delivery system with stabilising effect
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
KR20110097779A (ko) * 2008-11-21 2011-08-31 바이엘 파마 악티엔게젤샤프트 약물 전달 시스템
AU2015308987B2 (en) 2014-08-26 2021-02-18 Kaass Discovery As Methods, agents and compositions for treatment of inflammatory conditions
JP2021535183A (ja) * 2018-09-07 2021-12-16 トラスティーズ・オヴ・ダートマス・カレッジ C19骨格およびステロイドならびにそれらの使用および製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336432A1 (de) * 1973-07-13 1975-01-30 Schering Ag 3.17.18-trihydroxy-1.3.5(10)-oestratriene
US6154158A (en) * 1998-06-30 2000-11-28 Qualcomm Incorporated Digital-to-analog converter D.C. offset correction comparing converter input and output signals
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
PT1226155E (pt) * 1999-11-02 2007-07-26 Bayer Schering Pharma Ag 18-nor-esteróides como estrogénios selectivamente activos
WO2001077139A1 (de) * 2000-04-12 2001-10-18 Schering Aktiengesellschaft 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene

Also Published As

Publication number Publication date
NO20050127L (no) 2005-03-11
EP1517914A2 (de) 2005-03-30
ES2248770T3 (es) 2006-03-16
HK1081203A1 (en) 2006-05-12
CU23414B7 (es) 2009-09-08
ZA200500217B (en) 2006-03-29
PE20040613A1 (es) 2004-12-01
MXPA04012491A (es) 2005-06-08
KR20050009745A (ko) 2005-01-25
RS107004A (sr) 2006-10-27
HRP20050009A2 (en) 2005-04-30
IL165321A (en) 2009-08-03
TW200407331A (en) 2004-05-16
ATE303397T1 (de) 2005-09-15
WO2003104253A3 (de) 2004-09-16
CN1659181A (zh) 2005-08-24
HRP20050009B1 (hr) 2013-07-31
CA2486495A1 (en) 2003-12-18
JP4615998B2 (ja) 2011-01-19
CA2486495C (en) 2011-04-19
JP2005533053A (ja) 2005-11-04
ECSP055530A (es) 2005-03-10
DE50301116D1 (de) 2005-10-06
CR10289A (es) 2008-11-26
KR101006612B1 (ko) 2011-01-10
EA008442B1 (ru) 2007-06-29
BR0312140A (pt) 2005-04-05
AU2003242683B9 (en) 2009-08-27
AU2003242683A1 (en) 2003-12-22
UY27844A1 (es) 2003-12-31
DE10226326A1 (de) 2004-01-15
NO20050127D0 (no) 2005-01-10
AU2003242683B2 (en) 2009-07-02
DK1517914T3 (da) 2006-01-16
PL373090A1 (en) 2005-08-08
EA200401544A1 (ru) 2005-06-30
NO329563B1 (no) 2010-11-15
RS50878B (sr) 2010-08-31
CN1293090C (zh) 2007-01-03
EP1517914B1 (de) 2005-08-31
WO2003104253A2 (de) 2003-12-18
TWI286140B (en) 2007-09-01
PL209910B1 (pl) 2011-11-30
UA78062C2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
AR111425A2 (es) MODULADORES SELECTIVOS DE RECEPTORES DE ANDRÓGENOS (SARMs) Y COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN
ECSP077349A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
PE20080234A1 (es) Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas
CR20110131A (es) Derivados de prostaglandinas
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
UY28150A1 (es) Agentes terapeuticos
ES2174129T3 (es) Antagonistas de la hormona de liberacion de la gonadotropina.
DOP2007000018A (es) Moduladores de indol sulfonamida de receptores de progesterona
PE20040197A1 (es) Pirazolopiridinas sustituidas con carbamato
UY30736A1 (es) Compuestos quimicos 537
PE20060500A1 (es) Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
PE20080995A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroeteres(18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen
ECSP077323A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
PE20071251A1 (es) Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
NO20071922L (no) Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler
AR034392A1 (es) Compuestos derivados de 3, 16-dihidroxi-estra-1,3,5(10)-trieno, empleo de los mismos y de partes estructurales de los mismos y composiciones farmaceuticas que los contienen
CU23414B7 (es) Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva
BR0307903A (pt) derivados de arilsulfona
AR069386A1 (es) Formulaciones de emulsion de derivados de pirazolona y kits
UY27770A1 (es) Imidazolinilmetil aralquilsulfonamidas
CR9627A (es) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
PA8444901A1 (es) Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios
UY26665A1 (es) Estratrienos sustituidos como estrógenos selectivamente activos

Legal Events

Date Code Title Description
FG Grant, registration